Showing posts with label
Transcode Therapeudics
.
Show all posts
Showing posts with label
Transcode Therapeudics
.
Show all posts
Monday, September 23, 2024
IN treating Cancerous tumors, TransCode's technology is designed to target dysregulated microRNAs implicated in cancer progression, metastasis, and resistance to existing therapies.
›
Investor Report: TransCode Therapeutics Inc. (NASDAQ: RNAZ) Introduction TransCode Therapeutics Inc. is a clinical-stage biopharmaceutical...
›
Home
View web version
